Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: a randomized phase I clinical trial.
Dotres CP, Puga R, Ricardo Y, Broño CR, Paredes B, Echemendía V, Rosell S, González N, García-Rivera D, Valdés Y, Goldblatt D, Vérez-Bencomo V; Laboratory-Pneumococci Group; Havana-Pneumococci Group. Dotres CP, et al. Vaccine. 2014 Sep 15;32(41):5266-70. doi: 10.1016/j.vaccine.2014.06.094. Epub 2014 Jul 26. Vaccine. 2014. PMID: 25068497 Clinical Trial.
A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
Verez-Bencomo V, Fernández-Santana V, Hardy E, Toledo ME, Rodríguez MC, Heynngnezz L, Rodriguez A, Baly A, Herrera L, Izquierdo M, Villar A, Valdés Y, Cosme K, Deler ML, Montane M, Garcia E, Ramos A, Aguilar A, Medina E, Toraño G, Sosa I, Hernandez I, Martínez R, Muzachio A, Carmenates A, Costa L, Cardoso F, Campa C, Diaz M, Roy R. Verez-Bencomo V, et al. Science. 2004 Jul 23;305(5683):522-5. doi: 10.1126/science.1095209. Science. 2004. PMID: 15273395 Clinical Trial.
Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers.
Toraño G, Toledo ME, Baly A, Fernandez-Santana V, Rodriguez F, Alvarez Y, Serrano T, Musachio A, Hernandez I, Hardy E, Rodríguez A, Hernandez H, Aguilar A, Sánchez R, Diaz M, Muzio V, Dfana J, Rodríguez MC, Heynngnezz L, Verez-Bencomo V. Toraño G, et al. Clin Vaccine Immunol. 2006 Sep;13(9):1052-6. doi: 10.1128/CVI.00144-06. Clin Vaccine Immunol. 2006. PMID: 16960118 Free PMC article. Clinical Trial.
Prevalence of Pneumococcal Nasopharyngeal Carriage Among Children 2-18 Months of Age: Baseline Study Pre Introduction of Pneumococcal Vaccination in Cuba.
Toledo ME, Casanova MF, Linares-Pérez N, García-Rivera D, Toraño Peraza G, Barcos Pina I, Montes de Oca M, Rodriguez-Noda LM, Mirabal M, Paredes B, Chávez Amaro DM, Santana Mederos D, Valdés-Balbín Y, Verez-Bencomo V; Finlay Vaccine Institute Laboratory-Pneumococci Group and Cienfuegos Local Research Team Pneumococci Project. Toledo ME, et al. Pediatr Infect Dis J. 2017 Jan;36(1):e22-e28. doi: 10.1097/INF.0000000000001341. Pediatr Infect Dis J. 2017. PMID: 27649366
Influence of the Co-Administration of Heptavalent Conjugate Vaccine PCV7-TT on the Immunological Response Elicited by VA-MENGOC-BC® and Heberpenta®-L in Rabbits.
Espinosa-Viñals C, García-Rivera D, Rodríguez Noda L, Amador Gómez A, Nicot M, Valle O, Núñez JF, Martin Y, Santana D, Valdés Y, Vérez Bencomo V. Espinosa-Viñals C, et al. Immunol Invest. 2017 May;46(4):395-408. doi: 10.1080/08820139.2017.1288238. Epub 2017 Apr 5. Immunol Invest. 2017. PMID: 28379053
Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I.
Martínez CPD, Linares-Pérez N, Toledo-Romaní ME, Delgado YR, Gómez RP, Moreno BP, Rodriguez-Noda LM, Sosa MM, Mederos DS, García-Rivera D, Valdés-Balbín Y, Goldblatt D, Vérez-Bencomo V; Havana-Pneumococci Clinical Group; Finlay-Pneumococci Project. Martínez CPD, et al. Vaccine. 2018 Aug 6;36(32 Pt B):4944-4951. doi: 10.1016/j.vaccine.2018.05.027. Epub 2018 Jul 10. Vaccine. 2018. PMID: 30005948 Clinical Trial.
54 results